• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Laurus Labs’ net profit at Rs 48.8 crore in Q2 FY18

expressbpdNovember 14, 2017

Tag: Laurus Labs , net profit , Rs

Total revenue posted at Rs 538 crore

Hyderabad-based Laurus Labs’ net profit remained flat ₹48.8 crore in Q2 FY18, compared to ₹48.3 crore in Q2 FY17. The total revenue of company grew 4.3 per cent at Rs 538 crore (Rs 516 crore).

According to Satyanarayana Chava, CEO, Laurus Labs, the ARV (anti-retroviral) business witnessed a significant rise in revenues backed by strong customer offtake. He expects to maintain the momentum for the remaining half of the year.

Previous:Pfizer Q2 net dips to Rs 111 cr

Next:Merck Receives FDA Approval for GONAL-f Prefilled Pen

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Laurus Labs’ net profit at Rs 48.8 crore in Q2 FY18 | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

MDI Plain Canisters

MDI Plain Canisters
Ivermectin 1%+ Clorsulon 10% injectable solution

Ivermectin 1%+ Clorsulon 10% injectable solution
Disk disperser

Disk disperser
50L Enamel Glass Reactors

50L Enamel Glass Reactors
TC-14 Series Single Stage Medium Duty Regulators

TC-14 Series Single Stage Medium Duty Regulators
Wellgreen Oragnic Halal Herbal Althea Althaea Officinalis Marshmallow Root Extract Powder

Wellgreen Oragnic Halal Herbal Althea Althaea Officinalis Marshmallow Root Extract Powder
Carbopol®, Pemulen™, Noveon® and Pathway™ polymers

Carbopol®, Pemulen™, Noveon® and Pathway™ polymers
Dehydrated Parsley

Dehydrated Parsley
Ursodeoxycholic Acid ( UDCA )

Ursodeoxycholic Acid ( UDCA )
Welded Reducers (long Type)

Welded Reducers (long Type)

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service